Clinical trial NCT05007197: Learning Modality in Individuals With Diabetes Incompatible
Official title: The Effect of Diabetes Education Based on Learning Modality in Individuals With Diabetes Incompatible With Treatment on Compliance and Metabolic Goals: A Randomized Controlled Trial
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Diabetes Mellitus, Type 2
Keywords: Diabetes Education
Learning Style
Compliance With Treatment
Metabolic Target
Lead sponsor: Ege University
Sponsor class: OTHER
First posted: 2021-08-16
Enrollment: 60
Sex: ALL
Minimum age (years): 20
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Among the individuals who applied to the outpatient clinic and were eligible for inclusion in the study, the odd numbers were assigned to the application group, and the even numbers to the control group. The practice group of 30 people and the control group were divided into 3 groups as auditory (n: 10), visual (n: 10) and physical learners (n: 10).
Primary purpose: SUPPORTIVE_CARE

Brief summary: This study was planned to examine the effect of education based on learning styles in diabetic individuals who are incompatible with treatment, on treatment compliance and metabolic goals. The study was conducted as a randomized controlled study between January-September 2021 in Dokuz Eylül University Training and Research Hospital Endocrinology and Metabolic Diseases Polyclinic and Internal Medicine Polyclinic.

Detailed description: Among the individuals who applied to the outpatient clinic and were eligible for inclusion in the study, the odd numbers were assigned to the application group, and the even numbers to the control group.

The practice group of 30 people and the control group were divided into 3 groups as auditory (n: 10), visual (n: 10) and physical learners (n: 10). Research data; The Individual Identification Form was collected using the Patient Compliance Scale for Type 2 DM Treatment, the BIG 16 Learning Styles Inventory, the Standardized Mini Mental Test (SMMT) and the Metabolic Goal Control Form. The training group was given according to the learning styles. The auditory group in the post-training practice group; calling by phone, to the visual group; By SMS, to the physical group; reminder alerts were made by phone + SMS. Standard training was given to the control group. Metabolic target values of the application and control groups were examined at 3 and 6 months after the training.

Eligibility criteria: Inclusion Criteria:

1. age range of 20-65,
2. at least 6 months diagnosis,
3. ability to communicate in Turkish,
4. mentally stable, with no vision, verbal, or hearing impairments
5. not having any obstacle to continue the implementation phase of the research (for example, pregnancy plan, change of city, etc.),
6. not having advanced hearing-vision problems and another serious disease or serious complication due to diabetes (amputation, etc.)
7. it is to get a score between 55 and 150 (incompatible with treatment) from the Patient Compliance Scale in Type 2 DM Treatment.

Exclusion Criteria:

\*He/she received training on recurrent diabetes at Dokuz Eylul University Hospital.

to be,

* The patient's perception disorder and psychiatric disorder that prevent communication to be found,
* Having been diagnosed with cancer,
* Being pregnant,
* Blind retinopathy, advanced neuropathy and foot wound

Primary outcomes:
measure: Adherence to treatment
timeFrame: 6 months
measure: Physiological parameter
timeFrame: 6 months
measure: Effectiveness of education
timeFrame: 6 months
Secondary outcomes:
Other outcomes:
Locations:
city: Pazarcik
country: Turkey
facility: Kardaş Kin
state: Kahramanmaraş
Study officials:
affiliation: Ege UNİVERSITY
name: Ozlem KARDAS KIN
role: PRINCIPAL_INVESTIGATOR
References:
citation: Kardas Kin O, Tureyen A. The effect of diabetes education based on learning modality in individuals with diabetes incompatible with treatment on compliance and metabolic goals: A randomized controlled trial. Prim Care Diabetes. 2022 Feb;16(1):150-155. doi: 10.1016/j.pcd.2021.12.006. Epub 2021 Dec 18.